Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Number of holders
-
253
-
Total 13F shares, excl. options
-
165,499,147
-
Shares change
-
-1,967,453
-
Total reported value, excl. options
-
$1,741,215,310
-
Value change
-
-$25,432,141
-
Put/Call ratio
-
7.9%
-
Number of buys
-
133
-
Number of sells
-
-99
-
Price
-
$10.52
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q1 2023
276 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q1 2023.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 253 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 165,499,147 shares
.
Largest 10 shareholders include BlackRock Inc. (25,317,910 shares), Sarissa Capital Management LP (16,390,000 shares), VANGUARD GROUP INC (14,974,316 shares), STATE STREET CORP (10,481,842 shares), LSV ASSET MANAGEMENT (7,577,709 shares), WELLINGTON MANAGEMENT GROUP LLP (6,178,438 shares), CREDIT SUISSE AG/ (5,171,669 shares), RENAISSANCE TECHNOLOGIES LLC (4,637,753 shares), DIMENSIONAL FUND ADVISORS LP (4,609,079 shares), and BROWN CAPITAL MANAGEMENT LLC (3,933,933 shares).
This table shows the top 253 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.